James N. Topper M.D., Ph.D.

James N. Topper M.D., Ph.D.

Chief Executive Officer and Chairman at Frazier Lifesciences Acquisition Corporation

Are you James N. Topper M.D., Ph.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in James N. Topper M.D., Ph.D.'s network.
  • FOLLOW changes in James N. Topper M.D., Ph.D.'s employment.
  • CONNECT with James N. Topper M.D., Ph.D. through your network of contacts.

James N. Topper M.D., Ph.D.'s Executive Work History


Current
Board Member,
Board Member
Phathom Pharmaceuticals, Inc. 8-K on 09/26/2022
Phathom Pharmaceuticals, Inc.
Chief Executive Officer and Chairman,
Chief Executive Officer and Chairman
Frazier Lifesciences Acquisition Corporation 10-K on 03/26/2021
Frazier Lifesciences Acquisition Corporation
Board Member,
Board Member
Alpine Immune Sciences, Inc. DEF 14A on 04/29/2022
Alpine Immune Sciences, Inc.
Chairman,
Chairman
AnaptysBio, Inc. DEF 14A on 04/29/2022
AnaptysBio, Inc.
FRAZIER HEALTHCARE PARTNERS,
FRAZIER HEALTHCARE PARTNERS
Equilar on 10/26/2021
Amunix Pharmaceuticals, Inc.
Advisor,
Advisor
Equilar on 06/24/2022
Inipharm
Board Member,
Board Member
Equilar on 11/13/2022
Lassen Therapeutics
Board Member,
Board Member
Equilar on 02/23/2021
Seraxis Holdings, Inc.
Past
To view James N. Topper M.D., Ph.D.'s complete executive work history,
Education
B.S., University of Michigan, Ann Arbor
M.D., Stanford University - School of Medicine
Age
60
 

James N. Topper M.D., Ph.D.'s Biography


Jamie Topper, M.D., Ph.D., has more than 25 years of experience working with entrepreneurs to found and build successful therapeutics-focused companies. He is a Managing General Partner of Frazier Healthcare Partners’ Life Sciences team. Throughout his 14 years as a General Partner, Jamie has invested across over 35 companies encompassing a broad spectrum of life science and biopharmaceutical companies. Jamie has led and served as a board member for many of Frazier’s successful life sciences investments, including Acerta Pharma BV (sold to AstraZeneca), Calistoga Pharmaceuticals (co-founder, sold to Gilead Sciences), Mavupharma (sold to AbbVie), Rempex (sold to The Medicines Company), Incline (co-founder, sold to The Medicines Company), Alnara (sold to Lilly), Portola (co-founder, NASDAQ: PTLA), CoTherix (sold to Actelion), and Threshold (NASDAQ: THLD). He currently represents Frazier on the boards of Allena Pharmaceuticals (NASDAQ: ALNA), Alpine Immune Sciences (NASDAQ: ALPN), Amunix Pharmaceuticals, AnaptysBio (NASDAQ: ANAB), Aptinyx (NASDAQ: APTX), and Phathom Pharmaceuticals. He is also a board observer for Alcresta Therapeutics and Sojournix. Prior to joining Frazier, Jamie was the head of cardiovascular R&D at Millennium Pharmaceuticals and ran Millennium San Francisco (formerly COR Therapeutics). Before the merger of COR and Millennium, he served as the Vice President of Biology at COR and was responsible for all research activities. He served on the medical school faculties at Stanford and Harvard Medical School prior to joining COR. Jamie received his M.D. and Ph.D. in Biophysics from Stanford and holds a B.S. from the University of Michigan.

Source: Lassen Therapeutics on 11/13/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like James N. Topper M.D., Ph.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in James N. Topper M.D., Ph.D.'s network.
  • FOLLOW changes in James N. Topper M.D., Ph.D.'s employment.
  • CONNECT with James N. Topper M.D., Ph.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: James N. Topper M.D., Ph.D.

James N. Topper M.D., Ph.D.'s Connections (217)


Michelle Heath
Head of People, Amunix Pharmaceuticals, Inc.
Remy Durand PhD
Chief Business Officer, Alpine Immune Sciences, Inc.
Nicky Barber CPA
Senior Vice President of Finance, Amunix Pharmaceuticals, Inc.
Joe Hand J.D.
Executive Vice President, Global Human Resources and Corporate Services, Celgene Corporation
Shelley Hartman
Co-Founder and CEO, Aegle Therapeutics Corp
Hamza Suria
Former President, Chief Executive Officer and Director, AnaptysBio, Inc.
Terrie J. Curran
President, Chief Executive Officer and Director, Phathom Pharmaceuticals, Inc.
Dominic G. Piscitelli
Chief Financial Officer, ORIC Pharmaceuticals, Inc.
Christophe Couturier
EVP, AMEA, Avantor, Inc.
Gail A. Sloan
Chief Financial Officer, Biotheranostics